Pictet Asset Management Holding SA Boosts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Pictet Asset Management Holding SA raised its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 12.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 105,227 shares of the medical research company’s stock after purchasing an additional 11,839 shares during the quarter. Pictet Asset Management Holding SA owned 0.06% of IQVIA worth $20,678,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the business. Pine Valley Investments Ltd Liability Co grew its holdings in IQVIA by 0.5% during the third quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company’s stock worth $2,247,000 after acquiring an additional 50 shares during the period. Howard Capital Management Inc. boosted its position in shares of IQVIA by 4.9% during the 4th quarter. Howard Capital Management Inc. now owns 1,147 shares of the medical research company’s stock worth $225,000 after purchasing an additional 54 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of IQVIA by 1.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 5,434 shares of the medical research company’s stock valued at $1,068,000 after purchasing an additional 56 shares in the last quarter. Cypress Wealth Services LLC lifted its stake in shares of IQVIA by 4.8% in the fourth quarter. Cypress Wealth Services LLC now owns 1,243 shares of the medical research company’s stock valued at $244,000 after purchasing an additional 57 shares during the period. Finally, Harbor Investment Advisory LLC boosted its holdings in IQVIA by 4.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 1,286 shares of the medical research company’s stock worth $253,000 after buying an additional 58 shares in the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. lowered their price target on IQVIA from $240.00 to $232.00 and set an “overweight” rating on the stock in a report on Tuesday, February 18th. StockNews.com cut IQVIA from a “buy” rating to a “hold” rating in a research report on Wednesday, March 12th. Truist Financial reiterated a “buy” rating and issued a $263.00 price objective (up from $261.00) on shares of IQVIA in a research report on Monday, February 10th. William Blair restated an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. Finally, Stephens initiated coverage on shares of IQVIA in a research report on Friday, December 20th. They set an “overweight” rating and a $250.00 target price for the company. Five equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $249.05.

IQVIA Trading Down 0.6 %

NYSE IQV opened at $176.28 on Tuesday. The company has a 50-day moving average of $192.73 and a 200-day moving average of $205.61. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.84 and a quick ratio of 0.84. IQVIA Holdings Inc. has a 12 month low of $169.37 and a 12 month high of $253.84. The company has a market cap of $31.08 billion, a P/E ratio of 23.50, a P/E/G ratio of 1.99 and a beta of 1.50.

IQVIA (NYSE:IQV) last posted its quarterly earnings results on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing analysts’ consensus estimates of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. As a group, equities analysts predict that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.